Abstract

Bispecific antibodies represent a promising avenue whereby 2 different binding specificities of a single-chain antibody can be grafted into a common Fc fragment to generate one antibody-like molecule. Despite the promising efficacy of such modalities, they may lack manufacturability because of stability and aggregation issues. Herein, we performed a systematic buffer screening for an aggregation-prone therapeutic bispecific antibody (BsAb) during early stage development. To this end, various buffers (histidine, glutamate, acetate, and arginine) and buffer combinations, including arginine and glutamate (Arg + Glu), were evaluated for their stabilizing effects on BsAb. Specifically, we identified an equimolar combination of histidine and glutamate (His + Glu at pH 5.0) buffer that showed enhanced colloidal stability as measured by dynamic light scattering interaction parameter (kD). This implies a role of net protein-protein interaction in mediating aggregation propensity of the protein. Two-dimensional nuclear magnetic resonance and multiangle light scattering experiments suggest the formation of a reversible dimer as a potential precursor to overall aggregation process. Furthermore, 1D nuclear magnetic resonance studies suggest a unique mode of interaction of histidine with BsAb that can be modulated by other buffer components or ionic strength.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.